Amedica Corporation, a biomaterial company, announced today that it has entered into a distribution agreement with K2M that will provide surgeons and hospitals in Europe with access to Amedica's Silicon Nitride interbody spinal fusion devices. K2M is the largest privately-held spinal device company in the world.
Earlier this year, Amedica and K2M conducted a successful pilot program in select markets in Europe where surgeons were provided the opportunity to integrate Silicon Nitride interbody devices into their offerings for patients suffering from a variety of disorders requiring spinal fusion. This pilot program demonstrated a need in these strategic markets for spinal fusion devices devised from a different biomaterial.
"K2M is committed to providing the best and most innovative technologies to meet the needs of patients around the world suffering from spinal disorders and we believe our relationship with Amedica will help us further this goal," said Eric Major, K2M's President and Chief Executive Officer. "We are thrilled to make Amedica's Silicon Nitride interbody spinal fusion devices part of our comprehensive international product portfolio."